These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7865110)

  • 1. Chronic rejection of liver transplants revisited.
    Deligeorgi-Politi H; Wight DG; Calne RY; White DG
    Transpl Int; 1994; 7(6):442-7. PubMed ID: 7865110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A histometric analysis of chronically rejected human liver allografts: insights into the mechanisms of bile duct loss: direct immunologic and ischemic factors.
    Oguma S; Belle S; Starzl TE; Demetris AJ
    Hepatology; 1989 Feb; 9(2):204-9. PubMed ID: 2643544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic liver transplant rejection: definition and diagnosis.
    Wight DA
    Transplant Proc; 1996 Feb; 28(1):465-7. PubMed ID: 8644314
    [No Abstract]   [Full Text] [Related]  

  • 4. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation.
    Ludwig J; Wiesner RH; Batts KP; Perkins JD; Krom RA
    Hepatology; 1987; 7(3):476-83. PubMed ID: 3552923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanishing bile-duct syndrome following liver transplantation--is it reversible?
    Hubscher SG; Buckels JA; Elias E; McMaster P; Neuberger J
    Transplantation; 1991 May; 51(5):1004-10. PubMed ID: 1851580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total fibrous obliteration of main portal vein and portal foam cell venopathy in chronic hepatic allograft rejection.
    Jain D; Robert ME; Navarro V; Friedman AL; Crawford JM
    Arch Pathol Lab Med; 2004 Jan; 128(1):64-7. PubMed ID: 14692809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrous obliterative lesions of veins contribute to progressive fibrosis in chronic liver allograft rejection.
    Nakazawa Y; Jonsson JR; Walker NI; Kerlin P; Steadman C; Lynch SV; Strong RW; Clouston AD
    Hepatology; 2000 Dec; 32(6):1240-7. PubMed ID: 11093730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus infection of bile duct epithelial cells, hepatic artery and portal venous endothelium in relation to chronic rejection of liver grafts.
    Evans PC; Coleman N; Wreghitt TG; Wight DG; Alexander GJ
    J Hepatol; 1999 Nov; 31(5):913-20. PubMed ID: 10580590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that portal tract microvascular destruction precedes bile duct loss in human liver allograft rejection.
    Matsumoto Y; McCaughan GW; Painter DM; Bishop GA
    Transplantation; 1993 Jul; 56(1):69-75. PubMed ID: 8333070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic and biochemical changes during the evolution of chronic rejection of liver allografts.
    Neil DA; Hubscher SG
    Hepatology; 2002 Mar; 35(3):639-51. PubMed ID: 11870379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current concepts in cell-mediated hepatic allograft rejection leading to ductopenia and liver failure.
    Wiesner RH; Ludwig J; van Hoek B; Krom RA
    Hepatology; 1991 Oct; 14(4 Pt 1):721-9. PubMed ID: 1916676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis and treatment of bile duct loss after liver transplantation.
    Inomata Y; Tanaka K
    J Hepatobiliary Pancreat Surg; 2001; 8(4):316-22. PubMed ID: 11521176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cell hyperplasia in chronic rejection after liver transplantation.
    O'Keeffe C; Baird AW; Nolan N; McCormick PA
    Liver Transpl; 2002 Jan; 8(1):50-7. PubMed ID: 11799486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic artery stenosis in liver transplant recipients: prevalence and cholangiographic appearance of associated biliary complications.
    Orons PD; Sheng R; Zajko AB
    AJR Am J Roentgenol; 1995 Nov; 165(5):1145-9. PubMed ID: 7572493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of liver biopsy in evaluating acute allograft dysfunction following liver transplantation: a clinical histologic correlation of 34 liver transplants.
    Ray RA; Lewin KJ; Colonna J; Goldstein LI; Busuttil RW
    Hum Pathol; 1988 Jul; 19(7):835-48. PubMed ID: 2841220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of central perivenulitis in pediatric liver transplantation.
    Abraham SC; Freese DK; Ishitani MB; Krasinskas AM; Wu TT
    Am J Surg Pathol; 2008 Oct; 32(10):1479-88. PubMed ID: 18708942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Chlamydia pneumoniae in liver transplant patients with chronic allograft rejection.
    Lotz G; Simon S; Patonai A; Sótonyi P; Nemes B; Sergi C; Glasz T; Füle T; Nashan B; Schaff Z
    Transplantation; 2004 May; 77(10):1522-8. PubMed ID: 15239615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative analysis of T lymphocyte populations in human liver allografts undergoing rejection: the use of monoclonal antibodies and double immunolabeling.
    McCaughan GW; Davies JS; Waugh JA; Bishop GA; Hall BM; Gallagher ND; Thompson JF; Sheil AG; Painter DM
    Hepatology; 1990 Dec; 12(6):1305-13. PubMed ID: 1979551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokeratin immunostaining for detection of biliary epithelium: its use in counting bile ducts in cases of liver allograft rejection.
    Harrison RF; Patsiaoura K; Hubscher SG
    J Clin Pathol; 1994 Apr; 47(4):303-8. PubMed ID: 7517955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis of bile duct epithelial cells in hepatic allograft rejection.
    Nawaz S; Fennell RH
    Histopathology; 1994 Aug; 25(2):137-42. PubMed ID: 7982676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.